Document Detail

Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate.
MedLine Citation:
PMID:  7615207     Owner:  NLM     Status:  MEDLINE    
BACKGROUND & AIMS: To explain the greater hepatoprotective effect of tauroursodeoxycholic acid vs. ursodeoxycholic acid, the absorption, hepatic enrichment, and biotransformation of these bile acids (250 mg/day) were compared in rats. METHODS: Bile acids were determined in intestinal contents, feces, urine, plasma, and liver by gas chromatography-mass spectrometry. RESULTS: The concentration of ursodeoxycholate in the liver of animals administered tauroursodeoxycholic acid (175 +/- 29 nmol/g) was greater (P < 0.05) than in animals administered ursodeoxycholic acid (79 +/- 19 nmol/g). Hepatic lithocholate was substantially higher after ursodeoxycholic acid administration (21 +/- 10 nmol/g) than after tauroursodeoxycholic acid administration (12 +/- 1 nmol/g). A concomitant reduction in the proportion of hydrophobic bile acids occurred that was greatest during tauroursodeoxycholic acid administration. In the intestinal tract, the mass of ursodeoxycholate and its specific metabolites was greater in rats administered tauroursodeoxycholic acid (27.2 mg) than those administered ursodeoxycholic acid (13.2 mg). In feces, the proportion of lithocholate was 21.9% +/- 4.9% and 5.4% +/- 4.0% after ursodeoxycholic acid and tauroursodeoxycholic acid administration, respectively. CONCLUSIONS: Compared with ursodeoxycholic acid, tauroursodeoxycholic acid induces a greater decrease in the percent composition of more hydrophobic bile acids within the pool, limits lithocholate formation, and increases hepatic ursodeoxycholate concentration. These differences are explained by increased hepatic extraction and reduced intestinal biotransformation and not by enhanced absorption of the amidated species.
C M Rodrigues; B T Kren; C J Steer; K D Setchell
Related Documents :
7928367 - Evaluation of in vitro dissolution rates of thorium in uranium mill tailings.
6538337 - Sclerosing cholangitis: cholescintigraphy with tc-99m-labeled disida.
10027207 - Determination of mass transfer dissolution rate constants from critical time of dissolu...
10993187 - Medical dissolution of struvite nephrolithiasis using amino acid preparation in dogs.
2553967 - Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degrada...
690407 - The use of polyethyleneimine for demonstration of anionic sites in basement membranes a...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Gastroenterology     Volume:  109     ISSN:  0016-5085     ISO Abbreviation:  Gastroenterology     Publication Date:  1995 Aug 
Date Detail:
Created Date:  1995-08-22     Completed Date:  1995-08-22     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0374630     Medline TA:  Gastroenterology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  564-72     Citation Subset:  AIM; IM    
Department of Pediatrics, Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Feces / chemistry
Gas Chromatography-Mass Spectrometry
Intestines / chemistry
Lithocholic Acid / biosynthesis*
Liver / chemistry,  metabolism*
Plasma / chemistry
Rats, Sprague-Dawley
Taurochenodeoxycholic Acid / analysis,  metabolism*
Urine / chemistry
Ursodeoxycholic Acid / analysis,  metabolism*
Reg. No./Substance:
128-13-2/Ursodeoxycholic Acid; 14605-22-2/tauroursodeoxycholic acid; 434-13-9/Lithocholic Acid; 516-35-8/Taurochenodeoxycholic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the huma...
Next Document:  Influence of ductal pressure and infusates on activity and subcellular distribution of lysosomal enz...